Glucose metabolism-targeted therapy and withaferin A are effective for epidermal growth factor receptor tyrosine kinase inhibitor-induced drug-tolerant persisters.
about
Glucose metabolism-targeted therapy and withaferin A are effective for epidermal growth factor receptor tyrosine kinase inhibitor-induced drug-tolerant persisters.
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Glucose metabolism-targeted th ...... uced drug-tolerant persisters.
@ast
Glucose metabolism-targeted th ...... uced drug-tolerant persisters.
@en
type
label
Glucose metabolism-targeted th ...... uced drug-tolerant persisters.
@ast
Glucose metabolism-targeted th ...... uced drug-tolerant persisters.
@en
prefLabel
Glucose metabolism-targeted th ...... uced drug-tolerant persisters.
@ast
Glucose metabolism-targeted th ...... uced drug-tolerant persisters.
@en
P2093
P2860
P50
P356
P1433
P1476
Glucose metabolism-targeted th ...... duced drug-tolerant persisters
@en
P2093
Daisuke Tamura
Kazuyuki Kobayashi
Kei Kunimasa
Masatsugu Yamamoto
Miyako Satouchi
Motoko Tachihara
Ryota Dokuni
Shuntaro Tokunaga
Yoshihiro Nishimura
P2860
P304
P356
10.1111/CAS.13266
P577
2017-06-19T00:00:00Z